Epidemiology and treatment of Adamantiades-Behçet's disease in Germany: A healthcare claims database study.

J Eur Acad Dermatol Venereol · 2025 · PMC12023716 · PMID 39666543

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

16 The observed prevalence in 2016–2018 was stable in all age groups, except for patients aged 18–39 years, in whom a decreasing trend in ABD prevalence was noted.

also in 47,180 other papers

a possible trendno p-value reported

This may indicate that the true prevalence rates are between the ones reported in this study with a possible trend for misdiagnosis and the ones reported by the GeR‐ABD, which are specific but likely associated with underdiagnosis, as not all patients, but mostly severe cases, with ABD in Germany have been registered.

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.